Defender Capital, LLC. - Q3 2019 holdings

$113 Million is the total value of Defender Capital, LLC.'s 18 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 25.0% .

 Value Shares↓ Weighting
BRKB SellBERKSHIRE HATHAWAY INC DEL CL B$25,459,000
-10.3%
122,417
-8.2%
22.58%
-1.6%
DHR SellDANAHER CORPORATION$20,155,000
-5.0%
139,866
-6.1%
17.88%
+4.2%
MNST SellMONSTER BEVERAGE CORP$16,212,000
-12.5%
279,365
-3.5%
14.38%
-4.0%
STAA SellSTAAR SURGICAL COMPANY$15,076,000
-16.6%
584,228
-2.9%
13.37%
-8.5%
FTV BuyFORTIVE CORP$13,913,000
-15.4%
202,925
+0.1%
12.34%
-7.2%
CFX SellCOLFAX CORP$5,161,000
-4.2%
177,793
-10.0%
4.58%
+5.0%
LCTX NewLINEAGE CELL THERAPEUTICS INC$3,709,0003,794,045
+100.0%
3.29%
WINA SellWINMARK CORP$3,420,000
-2.2%
19,390
-3.4%
3.03%
+7.2%
VGSH NewVANGUARD SHORT-TERM GOVERNMENT BONDetf$2,803,00046,000
+100.0%
2.49%
KMI SellKINDER MORGAN INC DEL$2,431,000
-2.0%
117,878
-2.4%
2.16%
+7.5%
INO SellINOVIO PHARMACEUTICALS INC$1,279,000
-33.4%
622,300
-4.1%
1.14%
-26.9%
CGEN SellCOMPUGEN LTD ORD$1,257,000
+5.9%
297,333
-3.1%
1.12%
+16.1%
AAPL BuyAPPLE INC$524,000
+12.0%
2,355
+0.6%
0.46%
+22.7%
AMZN SellAMAZON COM INC$424,000
-14.0%
244
-5.8%
0.38%
-5.8%
AGE SellAGEX THERAPEUTICS INC$407,000
-56.6%
205,122
-22.0%
0.36%
-52.4%
CSCO SellCISCO SYS INC$215,000
-18.3%
4,349
-7.9%
0.19%
-10.3%
MSFT NewMICROSOFT CORP$211,0001,520
+100.0%
0.19%
FIT  FITBIT INC CL A$76,000
-12.6%
20,0000.0%0.07%
-4.3%
BTX ExitBIOTIME INC$0-4,119,800
-100.0%
-3.45%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-10-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL CL B20Q3 202324.4%
DANAHER CORPORATION COM20Q3 202318.3%
STAAR SURGICAL CORPORATION20Q3 202320.2%
FORTIVE CORPORATION20Q3 202314.3%
MONSTER BEVERAGE CORPORATION20Q3 202317.3%
APPLE INC20Q3 20230.6%
AMAZON INC COM20Q3 20230.4%
VANGUARD SHORT TERM TREASURY ETF IV17Q3 202323.9%
LINEAGE CELL THERAPEUTICS INC17Q3 20234.8%
COMPUGEN LTD ORD17Q1 20231.9%

View Defender Capital, LLC.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-01-23
13F-HR2023-10-23
13F-HR2023-07-18
13F-HR/A2023-05-16
13F-HR2023-04-27
13F-HR2023-01-12
13F-HR2022-10-18
13F-HR2022-07-26
13F-HR/A2022-06-07
13F-HR2022-04-22

View Defender Capital, LLC.'s complete filings history.

Compare quarters

Export Defender Capital, LLC.'s holdings